| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP&Pres, Periph Intervent | SVP&Pres, Periph Intervent
1 company
Mirviss Jeffrey B. is an EVP&Pres, Periph Intervent at BOSTON SCIENTIFIC CORP. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19, 2022 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 10,989 | $45.50 | $499,999.50 | -8.4% | -18.7% | +15.7% | |
| Mar 22, 2022 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 11,236 | $44.50 | $500,002.00 | -7.9% | -17.0% | +9.9% | |
| Jan 4, 2022 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 6,840 | $43.54 | $297,806.08 | -4.9% | +1.2% | +6.6% | |
| Jul 27, 2021 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 6,748 | $45.22 | $305,144.56 | -4.8% | -2.2% | -11.4% | |
| Apr 28, 2021 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sale+OE | 48,439 | $43.98 | $2,130,347.22 | -25.8% | +2.9% | -3.4% | |
| Apr 15, 2021 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sale+OE | 28,123 | $40.95 | $1,151,639.66 | -16.8% | +4.6% | +8.3% | |
| Feb 12, 2021 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sale+OE | 5,494 | $38.75 | $212,892.50 | -4.0% | +8.4% | +12.3% | |
| Jan 5, 2021 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 8,108 | $35.31 | $286,333.21 | -5.8% | - | - | |
| Dec 1, 2020 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sale+OE | 46,584 | $33.53 | $1,562,105.93 | -26.2% | - | - | |
| Sep 3, 2020 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 9,139 | $42.31 | $386,671.09 | -7.9% | - | - |